CD70 antibody based drugs: two different mechanisms of action for the treatment of multiple cancer types

被引：0
|
作者：
Terrett, Jonathan A. [1 ]
Pan, Chin [1 ]
Gangwar, Sanjeev [1 ]
Lu, Lisheng [1 ]
Chen, Liang [1 ]
Rao, Chetana [1 ]
Huber, Mary [1 ]
Sattari, Peter [1 ]
Do, Mary [1 ]
Dai, Rory [1 ]
Chong, Colin [1 ]
Soderberg, Carol [1 ]
Li, Hao [1 ]
Sufi, Bilal [1 ]
Boyd, Sharon [1 ]
Huang, Haichun [1 ]
Zhang, Jun [1 ]
Meaddough, Erika [1 ]
Guerlavais, Vincent [1 ]
Horgan, Killian [1 ]
Sharkov, Nick [1 ]
Cardarelli, Pina [1 ]
King, David [1 ]
Yao, Dapeng [1 ]
Pogue, Sarah [1 ]
机构：
[1] Medarex Inc, Milpitas, CA USA
来源：
CANCER RESEARCH | 2006年 / 66卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1995
引用
收藏
页数：2
相关论文
共 50 条
  • [1] CD70 CAR NK Cells in the Treatment of Multiple Myeloma
    Lin, Paul
    Silva, Francia C. Reyes
    Lin, Pei
    Gilbert, April L.
    Acharya, Sunil
    Cortes, Ana K. Nunez
    Banerjee, Pinaki
    Fang, Dexing
    Garcia, Luciana Melo
    Daher, May
    Basar, Rafet
    Patel, Krina K.
    Lee, Hans C.
    Orlowski, Robert Z.
    Rafei, Hind
    Marin, David
    Champlin, Richard E.
    Shpall, Elizabeth J.
    Rezvani, Katayoun
    BLOOD, 2023, 142
  • [2] CD70 expression in multiple types of carcinomas: new targets for auristatin-based anti-CD70 antibody-drug conjugate, SGN-75
    Smith, Leia
    Kostner, Heather
    Duniho, Steven
    Nesterova, Albina
    Sutherland, May
    Yu, Changpu
    Kim, Kristine
    Gordon, Kristine
    McEarchern, Julie
    Law, Che-Leung
    Ryan, Maureen
    CANCER RESEARCH, 2009, 69
  • [3] CD70 antibody therapy for the prevention and treatment of experimental Inflammatory Bowel Disease (IBD).
    Manocha, Monika
    Rietdijk, Svend
    Laouar, Amale
    Bhan, Atul
    Terhost, Cox
    Swamy, Manjunath N.
    FASEB JOURNAL, 2008, 22
  • [4] CD70 antibody-drug conjugate: A potential novel therapeutic agent for ovarian cancer
    Shiomi, Mayu
    Matsuzaki, Shinya
    Serada, Satoshi
    Matsuo, Koji
    Mizuta-Odani, Chihiro
    Jitsumori, Mariko
    Nakae, Ruriko
    Matsuzaki, Satoko
    Nakagawa, Satoshi
    Hiramatsu, Kosuke
    Miyoshi, Ai
    Kobayashi, Eiji
    Kimura, Toshihiro
    Ueda, Yutaka
    Yoshino, Kiyoshi
    Naka, Tetsuji
    Kimura, Tadashi
    CANCER SCIENCE, 2021, 112 (09) : 3655 - 3668
  • [5] MECHANISMS OF ACTION OF IMMUNOMODULATORY DRUGS - FROM TERATOGENICITY TO TREATMENT OF MULTIPLE MYELOMA
    Semochkin, S., V
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2022, 67 (02): : 240 - 260
  • [6] Novel Antibody-Based Therapeutic Agents Targeting CD70: A Potential Approach for Treating Waldenstrom's Macroglobulinemia
    Law, Che-Leung
    McEarchern, Julie A.
    Grewal, Iqbal S.
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 (01): : 90 - 93
  • [7] Transcriptomic landscape of tumor microenvironment in gastric cancer in treatment with different types of cancer drugs
    Yamashita, Hiroki
    Zhang, Jason Guoqiang
    Mashima, Chiaki
    Kamata, Ryo
    Yamamori, Tomoko
    Nakayama, Izuma
    Kawazoe, Akihito
    Shitara, Kohei
    Yano, Tomonori
    Xu, Qunli
    Ohashi, Akihiro
    Saito, Takeshi
    CANCER RESEARCH, 2024, 84 (06)
  • [8] MECHANISMS OF ACTION OF CANCER CHEMOTHERAPY DRUGS - ALTERNATIVE HYPOTHESIS BASED ON INHIBITION OF IMMUNOLOGICAL FUNCTION
    SADOFF, L
    CANCER CHEMOTHERAPY REPORTS PART 1, 1972, 56 (05): : 559 - 562
  • [9] Different mechanisms of CD200-CD200R induce diverse outcomes in cancer treatment
    Liao, Kang-Ling
    Watt, Kenton D.
    Protin, Tom
    MATHEMATICAL BIOSCIENCES, 2023, 365
  • [10] An Immune Based, Anti-CD138 Targeting Antibody for the Treatment of Multiple Myeloma
    Yu, Tengteng
    Xing, Lijie
    Lin, Liang
    Liu, Jiye
    Wen, Kenneth
    Cho, Shih-Feng
    Hsieh, Phillip
    Myette, James
    Chaganty, Bharat
    Adari, Hedy
    Tissire, Hamid
    Deotale, Ketan
    Shriver, Zach
    Munshi, Nikhil
    Tai, Yu-Tzu
    Anderson, Kenneth
    BLOOD, 2018, 132
12345